TERT and renal pelvis/ureter urothelial carcinoma: The recurrent TERT promoter mutations have been previously identified in UTUCs and UBCs, and the mutant DNA sequences are detectable in patient urine, thereby serving as a urinary biomarker for UTUC and UBC diagnostics 10-12, 24, 25.